Overview
Metformin and Oral Contraceptives in PCOS
Status:
Completed
Completed
Trial end date:
2013-04-01
2013-04-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
Background: PCOS is a common condition with a prevalence of 5-8 % in premenopausal women. More than 50% of PCOS patients are insulin resistant and have a diabetes risk 5-8 times higher than age- and weight-matched controls. Studies using insulin sensitizers in PCOS found increased insulin sensitivity and decreased insulin levels to be followed by decreased androgen levels and improved ovulatory function. No studies however, evaluated the long term effects of insulin sensitizing treatment. Oral contraceptives normalize menstrual cycles and suppress androgen levels in PCOS, however no long-term studies evaluated the effects of combined treatment with metformin and oral contraceptives in PCOS. Design: Randomized open study in 3*30 PCOS patients. Patients are randomised to 24 months of treatment with 1: metformin, 2: metformin and oral contraceptives or 3: oral contraceptives. Primary outcome measures: fasting insulin, AUC insulin. Secundary endpoints: BMI, WHR, LH, FSH, total and free-testosterone, c-peptid, urinary cortisol, AUC for insulin, glucose and c-peptid during OGTT. Inclusioncriteria: 1. Irregular menses or anovulaty cycles 2. High free testosterone > 0,035 nmol/l or hirsutism 3. PCO in vaginal US Criteria 1 and 2 OR 2 and 3. Design:Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Odense University HospitalTreatments:
Contraceptive Agents
Contraceptives, Oral
Metformin
Criteria
Inclusion Criteria:- Irregular menses or anovulaty cycles
- High free testosterone > 0.035 nmol/l or hirsutism
- PCO in vaginal US Criteria 1 and 2 OR 2 and 3
Exclusion Criteria:
- Age > 18 years
- Postmenopausal
- Diagnosis diabetes mellitus
- Use of medicine known to affect hormones measured in the project
- Pregnancy or planned pregnancy during study period
- Non-Caucasian
- Previous tromboembolic disease
- Heavy smoker > 35 years and BMI > 35 kg/m2